Cognex (CGNX) to Release Earnings on Wednesday

Cognex (NASDAQ:CGNX) is projected to issue its Q4 2025 results after the market closes on Wednesday, February 11th. Analysts expect Cognex to post earnings of $0.22 per share and revenue of $238.9210 million for the quarter. Individuals may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, February 12, 2026 at 8:30 AM ET.

Cognex Price Performance

Shares of CGNX stock opened at $40.85 on Wednesday. The company has a fifty day moving average price of $38.15 and a two-hundred day moving average price of $40.90. Cognex has a one year low of $22.67 and a one year high of $49.76. The stock has a market cap of $6.85 billion, a P/E ratio of 63.83 and a beta of 1.53.

Institutional Investors Weigh In On Cognex

Several institutional investors have recently made changes to their positions in the stock. Northwestern Mutual Wealth Management Co. increased its stake in shares of Cognex by 183.7% in the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 6,048 shares of the scientific and technical instruments company’s stock valued at $274,000 after purchasing an additional 3,916 shares during the last quarter. iSAM Funds UK Ltd acquired a new stake in Cognex in the third quarter valued at about $135,000. Van ECK Associates Corp boosted its stake in Cognex by 17.2% in the third quarter. Van ECK Associates Corp now owns 4,446 shares of the scientific and technical instruments company’s stock valued at $201,000 after buying an additional 653 shares in the last quarter. Private Advisor Group LLC bought a new position in Cognex in the third quarter valued at about $202,000. Finally, Parallel Advisors LLC raised its stake in Cognex by 30.3% during the third quarter. Parallel Advisors LLC now owns 2,164 shares of the scientific and technical instruments company’s stock worth $98,000 after acquiring an additional 503 shares in the last quarter. 88.12% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

CGNX has been the subject of several recent analyst reports. JPMorgan Chase & Co. reiterated an “underweight” rating and issued a $35.00 target price (down from $45.00) on shares of Cognex in a research note on Wednesday, December 3rd. KeyCorp reiterated an “overweight” rating and set a $50.00 target price on shares of Cognex in a research note on Friday, October 31st. Barclays set a $54.00 target price on Cognex and gave the stock an “overweight” rating in a report on Monday, January 12th. The Goldman Sachs Group raised Cognex from a “sell” rating to a “buy” rating and raised their price target for the company from $42.00 to $50.00 in a report on Tuesday, December 16th. Finally, DA Davidson set a $38.00 price objective on shares of Cognex and gave the company a “neutral” rating in a report on Monday, November 3rd. Eight research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $45.64.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.